Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer

Fig. 8

The analysis of drug sensitivity based on CRL signature in HNSCC. a Drug sensitivity (IC50) analysis of Cisplatin, Cytarabine, Docetaxel, Doxorubicin, Etoposide, Gemcitabine, Methotrexate, Paclitaxel, Dasatinib and Erlotinib. b The correlation of drug sensitivity (IC50) and cisplatin, Cytarabine, Docetaxel, Doxorubicin, Etoposide, Gemcitabine, Methotrexate, Paclitaxel, Dasatinib, Erlotinib

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us